Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Cheniere Energy
CQP
$31.3B
| $8.18M | 0.01% |
151,027
+4,564
| +3% | +$235K |
|
1077
Guardant Health
GH
$22.6B
| $8.18M | 0.01% |
276,099
+73,227
| +36% | +$2.57M |
|
|
FTCH
1078
CALL
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $8.15M | 0.01% |
+3,900,000
| New | +$15.9M |
|
|
DCH
1079
Dauch Corp
DCH
$1.51B
| $8.15M | 0.01% |
1,122,458
+942,186
| +523% | +$7.57M |
|
|
CFLT
1080
DELISTED
Confluent
CFLT
| $8.13M | 0.01% |
274,619
-36,762
| -12% | -$1.23M |
|
1081
Essential Utilities
WTRG
$11.4B
| $8.12M | 0.01% |
236,405
-44,689
| -16% | -$1.73M |
|
1082
Intellia Therapeutics
NTLA
$1.67B
| $8.11M | 0.01% |
256,626
+33,558
| +15% | +$1.3M |
|
1083
PUT
T-Mobile US
TMUS
$190B
| $8.09M | 0.01% |
57,800
-5,600
| -9% | -$776K |
|
1084
Oshkosh
OSK
$9.59B
| $8.09M | 0.01% |
84,748
-35,899
| -30% | -$3.48M |
|
1085
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
| $8.08M | 0.01% |
326,884
+32,601
| +11% | +$880K |
|
1086
Lumen
LUMN
$6.44B
| $8.08M | 0.01% |
5,690,137
+40,589
| +0.7% | +$68.7K |
|
1087
Embecta
EMBC
$262M
| $8.04M | 0.01% |
533,905
+481,426
| +917% | +$9.03M |
|
1088
Organon & Co
OGN
$3.57B
| $8.02M | 0.01% |
462,114
+131,725
| +40% | +$2.75M |
|
1089
TORM
TRMD
$3.02B
| $7.99M | 0.01% |
290,182
-180,125
| -38% | -$4.57M |
|
1090
New Oriental
EDU
$8.98B
| $7.98M | 0.01% |
136,372
-2,369
| -2% | -$124K |
|
1091
Berkshire Hathaway Class A
BRK.A
$1.12T
| $7.97M | 0.01% |
15
-12
| -44% | -$6.47M |
|
1092
Yeti Holdings
YETI
$3.95B
| $7.95M | 0.01% |
164,892
-33,217
| -17% | -$1.48M |
|
1093
Ralph Lauren
RL
$23.6B
| $7.94M | ﹤0.01% |
68,355
-45,548
| -40% | -$5.52M |
|
|
VTYX
1094
DELISTED
Ventyx Biosciences
VTYX
| $7.93M | ﹤0.01% |
228,220
+204,762
| +873% | +$7.08M |
|
1095
CALL
Corteva
CTVA
$51.3B
| $7.92M | ﹤0.01% |
+154,800
| New | +$8.2M |
|
1096
AGCO
AGCO
$7.2B
| $7.91M | ﹤0.01% |
66,836
-7,791
| -10% | -$990K |
|
1097
NetEase
NTES
$84.7B
| $7.88M | ﹤0.01% |
78,645
-3,114
| -4% | -$319K |
|
1098
PUT
Vertex Pharmaceuticals
VRTX
$126B
| $7.86M | ﹤0.01% |
+22,600
| New | +$7.9M |
|
1099
Bank of Hawaii
BOH
$3.13B
| $7.86M | ﹤0.01% |
158,093
-10,476
| -6% | -$538K |
|
1100
PUT
Thermo Fisher Scientific
TMO
$220B
| $7.8M | ﹤0.01% |
15,400
-2,800
| -15% | -$1.49M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.